CA-125 Monitoring in Ovarian Cancer: Patient Survey Responses to the Results of the MRC/EORTC CA-125 Surveillance Trial

A reliable biomarker (e.g. CA-125) that could both monitor the course of the illness and identify disease progression to permit effective intervention to prevent symptoms and prolong survival would be useful in the management of ovarian cancer. But will somewhat earlier detection of disease recurren...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Oncology 2010-01, Vol.78 (1), p.1-2
Hauptverfasser:	Markman, Maurie, Petersen, Judith, Belland, Angela, Burg, Kenda
Format:	Artikel
Sprache:	eng
Schlagworte:	Biomarkers Biomarkers, Tumor - blood CA-125 Antigen - blood Editorial Female Health Care Surveys Humans Monitoring systems Mortality Ovarian cancer Ovarian Neoplasms - blood Ovarian Neoplasms - diagnosis Randomized Controlled Trials as Topic
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	A reliable biomarker (e.g. CA-125) that could both monitor the course of the illness and identify disease progression to permit effective intervention to prevent symptoms and prolong survival would be useful in the management of ovarian cancer. But will somewhat earlier detection of disease recurrence actually improve outcome?
ISSN:	0030-2414 1423-0232
DOI:	10.1159/000292352